PQM Stock Overview
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
PetMed Express, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$4.25 |
52 Week High | US$15.24 |
52 Week Low | US$4.25 |
Beta | 0.70 |
1 Month Change | -8.76% |
3 Month Change | -37.14% |
1 Year Change | -71.90% |
3 Year Change | -84.54% |
5 Year Change | -78.14% |
Change since IPO | -29.55% |
Recent News & Updates
Recent updates
Shareholder Returns
PQM | DE Specialty Retail | DE Market | |
---|---|---|---|
7D | -0.2% | 3.7% | 1.3% |
1Y | -71.9% | -19.4% | 6.4% |
Return vs Industry: PQM underperformed the German Specialty Retail industry which returned -19.5% over the past year.
Return vs Market: PQM underperformed the German Market which returned 7.5% over the past year.
Price Volatility
PQM volatility | |
---|---|
PQM Average Weekly Movement | 5.6% |
Specialty Retail Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PQM's share price has been volatile over the past 3 months.
Volatility Over Time: PQM's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 302 | Matt Hulett | https://www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
PQM fundamental statistics | |
---|---|
Market cap | €88.82m |
Earnings (TTM) | -€5.62m |
Revenue (TTM) | €250.34m |
0.4x
P/S Ratio-15.8x
P/E RatioIs PQM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PQM income statement (TTM) | |
---|---|
Revenue | US$270.52m |
Cost of Revenue | US$195.31m |
Gross Profit | US$75.21m |
Other Expenses | US$81.29m |
Earnings | -US$6.08m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.30 |
Gross Margin | 27.80% |
Net Profit Margin | -2.25% |
Debt/Equity Ratio | 0% |
How did PQM perform over the long term?
See historical performance and comparison